vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Hanover Bancorp, Inc. (HNVR). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $18.6M, roughly 1.2× Hanover Bancorp, Inc.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 3.3%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 6.1%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Hanover Bancorp, Inc. is a U.S. regional bank holding company based in Maryland. It offers retail and commercial banking services including deposits, business loans, mortgages, personal lending and wealth management, serving consumers, SMEs and local groups across Maryland and adjacent mid-Atlantic markets.

ADCT vs HNVR — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.2× larger
ADCT
$23.1M
$18.6M
HNVR
Growing faster (revenue YoY)
ADCT
ADCT
+33.0% gap
ADCT
36.4%
3.3%
HNVR
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
6.1%
HNVR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
HNVR
HNVR
Revenue
$23.1M
$18.6M
Net Profit
$33.0K
Gross Margin
Operating Margin
-77.7%
0.7%
Net Margin
0.2%
Revenue YoY
36.4%
3.3%
Net Profit YoY
-99.2%
EPS (diluted)
$0.04
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
HNVR
HNVR
Q4 25
$23.1M
$18.6M
Q3 25
$15.8M
$18.0M
Q2 25
$18.1M
$18.4M
Q1 25
$17.4M
$18.4M
Q4 24
$16.9M
$18.0M
Q3 24
$18.0M
$17.1M
Q2 24
$17.0M
$16.9M
Q1 24
$17.8M
$16.5M
Net Profit
ADCT
ADCT
HNVR
HNVR
Q4 25
$33.0K
Q3 25
$-41.0M
$3.5M
Q2 25
$-56.6M
$2.4M
Q1 25
$-38.6M
$1.5M
Q4 24
$3.9M
Q3 24
$-44.0M
$3.5M
Q2 24
$-36.5M
$844.0K
Q1 24
$-46.6M
$4.1M
Operating Margin
ADCT
ADCT
HNVR
HNVR
Q4 25
-77.7%
0.7%
Q3 25
-196.6%
25.9%
Q2 25
-244.1%
18.4%
Q1 25
-163.5%
9.6%
Q4 24
-191.8%
28.9%
Q3 24
-197.4%
27.1%
Q2 24
-170.5%
6.9%
Q1 24
-188.3%
32.7%
Net Margin
ADCT
ADCT
HNVR
HNVR
Q4 25
0.2%
Q3 25
-260.1%
19.4%
Q2 25
-313.2%
13.3%
Q1 25
-221.8%
8.3%
Q4 24
21.7%
Q3 24
-244.1%
20.7%
Q2 24
-214.6%
5.0%
Q1 24
-261.1%
24.6%
EPS (diluted)
ADCT
ADCT
HNVR
HNVR
Q4 25
$0.04
$0.00
Q3 25
$-0.30
$0.47
Q2 25
$-0.50
$0.33
Q1 25
$-0.36
$0.20
Q4 24
$-0.26
$0.52
Q3 24
$-0.42
$0.48
Q2 24
$-0.38
$0.11
Q1 24
$-0.56
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
HNVR
HNVR
Cash + ST InvestmentsLiquidity on hand
$261.3M
$208.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$200.3M
Total Assets
$323.1M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
HNVR
HNVR
Q4 25
$261.3M
$208.9M
Q3 25
$234.7M
$167.6M
Q2 25
$264.6M
$164.5M
Q1 25
$194.7M
$160.2M
Q4 24
$250.9M
$162.9M
Q3 24
$274.3M
$141.2M
Q2 24
$300.1M
$141.1M
Q1 24
$234.3M
$136.5M
Stockholders' Equity
ADCT
ADCT
HNVR
HNVR
Q4 25
$-185.8M
$200.3M
Q3 25
$-238.2M
$201.8M
Q2 25
$-199.2M
$198.9M
Q1 25
$-238.2M
$196.6M
Q4 24
$-202.6M
$196.6M
Q3 24
$-171.9M
$192.3M
Q2 24
$-131.7M
$190.1M
Q1 24
$-194.4M
$189.5M
Total Assets
ADCT
ADCT
HNVR
HNVR
Q4 25
$323.1M
$2.4B
Q3 25
$289.8M
$2.3B
Q2 25
$321.6M
$2.3B
Q1 25
$272.5M
$2.3B
Q4 24
$322.0M
$2.3B
Q3 24
$349.1M
$2.3B
Q2 24
$371.8M
$2.3B
Q1 24
$308.0M
$2.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
HNVR
HNVR
Operating Cash FlowLast quarter
$-31.1M
$13.1M
Free Cash FlowOCF − Capex
$12.2M
FCF MarginFCF / Revenue
65.5%
Capex IntensityCapex / Revenue
0.0%
4.7%
Cash ConversionOCF / Net Profit
395.48×
TTM Free Cash FlowTrailing 4 quarters
$16.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
HNVR
HNVR
Q4 25
$-31.1M
$13.1M
Q3 25
$-29.6M
$2.7M
Q2 25
$-24.1M
$-2.1M
Q1 25
$-56.3M
$4.1M
Q4 24
$-21.9M
$5.4M
Q3 24
$-25.0M
$-547.0K
Q2 24
$-32.8M
$-3.1M
Q1 24
$-44.1M
$3.6M
Free Cash Flow
ADCT
ADCT
HNVR
HNVR
Q4 25
$12.2M
Q3 25
$2.4M
Q2 25
$-2.2M
Q1 25
$-56.6M
$3.9M
Q4 24
$-21.9M
$4.1M
Q3 24
$-25.3M
$-876.0K
Q2 24
$-32.9M
$-4.5M
Q1 24
$-44.6M
$3.3M
FCF Margin
ADCT
ADCT
HNVR
HNVR
Q4 25
65.5%
Q3 25
13.5%
Q2 25
-11.7%
Q1 25
-325.2%
21.2%
Q4 24
-129.8%
23.1%
Q3 24
-140.2%
-5.1%
Q2 24
-193.0%
-26.9%
Q1 24
-250.0%
19.9%
Capex Intensity
ADCT
ADCT
HNVR
HNVR
Q4 25
0.0%
4.7%
Q3 25
0.0%
1.8%
Q2 25
0.0%
0.5%
Q1 25
1.5%
1.2%
Q4 24
0.5%
7.2%
Q3 24
1.2%
1.9%
Q2 24
0.2%
8.6%
Q1 24
3.0%
1.9%
Cash Conversion
ADCT
ADCT
HNVR
HNVR
Q4 25
395.48×
Q3 25
0.79×
Q2 25
-0.84×
Q1 25
2.70×
Q4 24
1.39×
Q3 24
-0.15×
Q2 24
-3.68×
Q1 24
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons